| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |